AFTER JULIE SIMONSON SURVIVED A SEXUAL assault, she turned to the 7-Eleven across the street for comfort food. Her weight skyrocketed, along with her shame.
"I would cope by basically overeating," the psychotherapist from Philadelphia says, recalling how her health declined in the aftermath of the attack.
Eventually she turned to gastric bypass surgery and lost 160 pounds. Simonson, 50, endured skin removal surgery, a tummy tuck and an arm lift, but the pounds slowly came back, despite her best efforts to restrict calories and work with a trainer.
Finally, in 2023, Simonson's doctor put her on Mounjaro, one of the new class of highly touted diabetes and weight-loss drugs, and the pounds finally came off and stayed off. She says she feels amazing.
But beneath Simonson's joy, she's found a darker side to living at a healthy weight-people are treating her like a celebrity, even though she's the same person she's always been.
"My interests haven't changed. My sense of humor hasn't changed. Fundamentally who I am hasn't changed," Simonson says indignantly. "That's why it's frustrating when people are nicer to me because I'm not really any different."
As tens of millions of Americans reap the benefits of new obesity therapies, some are finding a bitter confirmation of the fatphobia they've experienced all their lives-and are grappling with how to deal with theirr own, internal bias now that they're "on the other side."
It's yet another aspect of a new health and weight revolution powered by a class of drugs called GLP-1 agonists that's reshaping American society.
As many Americans lose weight to improve their health, their old bodies-and memories of past mistreatment-continue to cast a shadow over them.
They're learning all over, in a new way, how awful neighbors, co-workers and strangers can be.
この記事は Newsweek Europe の August 16 - 23, 2024 (Double Issue) 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Newsweek Europe の August 16 - 23, 2024 (Double Issue) 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
Ray Romano
THE MAJOR THING ABOUT NETFLIX'S NO GOOD DEED THAT APPEALED TO Ray Romano was that it was unlike anything he'd done before.
Has J.K. Rowling Won the Culture War?
After years of backlash over trans issues, the Harry Potter author has received major business backing
'This Murder Is a Symbol of the Times'
Conservatives and liberals agree on the state of the health care industry following the killing of Brian Thompson
The Defense Industry's Fight With ESG
EUROPEAN DEFENSE COMPANIES, ESPECIALLY smaller businesses, are being blocked from investment they sorely need by sustainability rules, a senior NATO official and several industry figures have said.
Nothin' Lasts Forever
Taylor Swift's Eras Tour' ends its record-breaking run..
SPY IN THE SKY
CHINA FACES ACCUSATIONS of ESPIONAGE and WEAPONIZING OUTER SPACE as it BUILDS a NEW OBSERVATORY in CHILE critics say WILL BE USED for MILITARY PURPOSES
Margo Martindale
\"WHO KNEW THAT A BARREL OF MAPLE SYRUP IS WORTH MORE THAN A barrel of oil?\"
Malala Yousafzai
\"AFGHANISTAN IS THE ONLY COUNTRY IN THE world where girls are banned from access to education and women are limited from work.\"
In the Eyes of the Law
Jude Law is unrecognizable as an FBI agent on the trail of aneo-Naziterrorist group in real-crime drama The Order
AMERICA'S Most Responsible Companies 2025
IN THE FACE OF ISSUES LIKE CLIMATE CHANGE and wage inequality, consumers care about the impact of the businesses they interact with and companies are responding.